H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Low-cost CRISPR-based paper strip test offers rapid influenza diagnosis

Low-cost CRISPR-based paper strip test offers rapid influenza diagnosis

The chicken and egg problem of fighting another flu pandemic

The chicken and egg problem of fighting another flu pandemic

Farmworkers face high-risk exposures to bird flu, but testing isn’t reaching them

Farmworkers face high-risk exposures to bird flu, but testing isn’t reaching them

New drug-like molecules show promise in preventing influenza by blocking virus entry

New drug-like molecules show promise in preventing influenza by blocking virus entry

New influenza vaccine strategies aim to enhance protection with T-cell responses

New influenza vaccine strategies aim to enhance protection with T-cell responses

Bird flu is bad for poultry and dairy cows. It’s not a dire threat for most of us — yet.

Bird flu is bad for poultry and dairy cows. It’s not a dire threat for most of us — yet.

Study shows potential for universal flu vaccine with broad antibody response

Study shows potential for universal flu vaccine with broad antibody response

Higher COVID-19 death risk found in sickle cell disease and trait patients

Higher COVID-19 death risk found in sickle cell disease and trait patients

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Researchers develop promising recombinant flu vaccine using nanoliposome technology

CDC studies show effectiveness of flu vaccines across all age groups

CDC studies show effectiveness of flu vaccines across all age groups

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

Vaccines safe for pregnant women with HIV but show reduced immune response

Vaccines safe for pregnant women with HIV but show reduced immune response

How does the nasal cavity's immune system combat SARS-CoV-2?

How does the nasal cavity's immune system combat SARS-CoV-2?

Curcumin spray shows promise in fighting SARS-CoV-2 and flu viruses

Curcumin spray shows promise in fighting SARS-CoV-2 and flu viruses

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Previously unrecognized class of antibodies can broadly neutralize multiple virus strains

Previously unrecognized class of antibodies can broadly neutralize multiple virus strains

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

New 4-in-1 test can differentiate between swine flu, COVID-19, RSV, and influenza

New 4-in-1 test can differentiate between swine flu, COVID-19, RSV, and influenza

Study highlights variable use and rising costs of antivirals in treating pediatric influenza in the U.S.

Study highlights variable use and rising costs of antivirals in treating pediatric influenza in the U.S.

New quantitative analysis of how flu viruses evolved may help predict future strains

New quantitative analysis of how flu viruses evolved may help predict future strains

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.